Sign in
4

Changes in Ownership

INCYTE CORP Filed Acc 0002050035-26-000002

EVP, Head of US Oncology sold 10,856 shares at $109.07 ($1,184,064)

  • EVP, Head of US Oncology gave up 8,264 shares (to pay taxes)
  • Traded under a Rule 10b5-1 plan

From the SEC's structured data for this filing

Trades in this filing

Issa Mohamed Khairie · EVP, Head of US Oncology

Table I: Non-derivative

2 lines
Date Transaction Shares Price Value Owned after D/I
2026-01-06 Shares withheld for taxes : show line 1 in the form 10b5-1 −8,264 $106.66 $881,438 76,988 D
2026-01-07 Sale : show line 2 in the form 10b5-1 −10,856 $109.07 $1,184,064 66,132 D
Open-market sales · 10,856 sh · avg $109.07 · $1,184,064
Loading xslF345X05/wk-form4_1767906216.xml…